Impact of enzalutamide (ENZA) vs. bicalutamide (BIC) on health-related quality of life (HRQoL) of patients (pts) with castration-resistant prostate cancer (CRPC): STRIVE study. Meeting Abstract

cited authors

  • Concepcion, Raoul; Armstrong, Andrew J.; Karsh, Lawrence Ivan; Holmstrom, Stefan; Ivanescu, Cristina; Dunshee, Curtis; Agarwal, Neeraj; O'Kelly, Michael; Naidoo, Shevani; Olsson, Carl A.; Phung, De; Ratitch, Bohdana; Wang, Fong; Kral, Pavol; Penson, David F.

Publication Date

  • February 20, 2018

webpage

published in

category

volume

  • 36

issue

  • 6